Introduction:

although respiratory failure remains the hallmark and leading cause of death from moderate to severe COVID-19, several cardiovascular complications and numerous cases of thromboembolic disease have been reported.

Objectives:

to determine the prevalence of thrombotic arterial complications in patients hospitalized for COVID-19 in a regional hospital in Paraguay during 2020.

Methodology:

the study was quantitative, observational and descriptive with an analytical component that included patients with a diagnosis of COVID-19 confirmed by PCR or IgM-IgG serology who were admitted to the Regional Hospital, selected through non-probabilistic convenience sampling.

Results:

of 282 clinical records, 71% corresponded to males with a median age of 60 years (P25=31 P75=65). 88% of the patients presented a thrombotic arterial complication, where the most altered laboratory value was CRP in 95%. The association between the variables of comorbidity (Peripheral Arterial Disease, COPD, Coronary Heart Disease, Stroke) and prevalence of thrombotic arteries and thus also the D-Dimer (17671,01±22356,21), yielded a statistically significant result.

Conclusions:

the high rate of thrombotic arterial complications in patients with COVID-19 is alarming, in addition to the association of D-Dimer and comorbidities with arterial complications marks the north of the future of their prognosis.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )